SELLAS Life Sciences Group (SLS) Q2 2026 Earnings

12MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.11
-0.09
-0.07
-0.05

Details

Expected EPS
-0.06
Actual EPS
-0.05
Surprise EPS
0.01
Surprise Percent
+16.67%

Description

SELLAS Life Sciences Group (SLS) has reported earnings of -0.05 per share for Q2 2026.

0 Comments

Share your thoughts